Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	PMS2 MYH10 HYOU1 EIF4A3 WRN PSMC4 TOMM20 CHD1 UPF1 BCS1L HSPA13 ABCA6 IGHMBP2 DNAH17 SMARCA1 MACF1 ATP2B1 DNAH9 ACSM2B	7.43e-07	614	164	19	GO:0140657
GeneOntologyMolecularFunction	protein-transporting ATPase activity	TOMM20 BCS1L	6.70e-05	2	164	2	GO:0015450
GeneOntologyMolecularFunction	ATP hydrolysis activity	PMS2 EIF4A3 WRN PSMC4 CHD1 UPF1 BCS1L HSPA13 ABCA6 IGHMBP2 MACF1 ATP2B1 DNAH9	7.45e-05	441	164	13	GO:0016887
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DOCK4 TRIO CYTH3 IQSEC2 ARHGEF12 CCDC88A MCF2L VAV1 PLCE1	1.27e-04	231	164	9	GO:0005085
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL6A1 COL6A3 COL12A1 COL6A6 TNC MATN2 LAMA2 PODN	1.66e-04	188	164	8	GO:0005201
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	PMS2 EIF4A3 WRN PSMC4 CHD1 UPF1 BCS1L HSPA13 ABCA6 IGHMBP2 RHOBTB2 MFN2 MACF1 GNA12 GNAS ATP2B1 DNAH9	2.24e-04	775	164	17	GO:0017111
GeneOntologyMolecularFunction	enzyme regulator activity	DOCK4 COL6A3 TBC1D9B GARNL3 TRIO CYTH3 PARP8 SIPA1L3 IQSEC2 CAPN3 ARHGEF12 PSME2 NCS1 PPP4R3B PTPA CCDC88A TBC1D4 STRADA CCAR2 GNA12 GNAS MCF2L VAV1 HSPB2 PLCE1	2.35e-04	1418	164	25	GO:0030234
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DOCK4 TBC1D9B GARNL3 TRIO CYTH3 SIPA1L3 IQSEC2 ARHGEF12 CCDC88A TBC1D4 MCF2L VAV1 PLCE1	2.93e-04	507	164	13	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DOCK4 TBC1D9B GARNL3 TRIO CYTH3 SIPA1L3 IQSEC2 ARHGEF12 CCDC88A TBC1D4 MCF2L VAV1 PLCE1	2.93e-04	507	164	13	GO:0030695
GeneOntologyMolecularFunction	modification-dependent protein binding	ANK3 CHD1 ZZEF1 PWWP2A GLYR1 L3MBTL3 VAV1 PML	3.09e-04	206	164	8	GO:0140030
GeneOntologyMolecularFunction	enzyme activator activity	DOCK4 TBC1D9B GARNL3 PARP8 SIPA1L3 ARHGEF12 PSME2 NCS1 PPP4R3B PTPA CCDC88A TBC1D4 STRADA GNAS HSPB2	3.44e-04	656	164	15	GO:0008047
GeneOntologyMolecularFunction	double-stranded DNA helicase activity	UPF1 IGHMBP2	3.98e-04	4	164	2	GO:0036121
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL6A1 COL6A3 COL12A1 COL6A6	5.47e-04	46	164	4	GO:0030020
GeneOntologyMolecularFunction	pyrophosphatase activity	PMS2 EIF4A3 WRN PSMC4 CHD1 UPF1 BCS1L HSPA13 ABCA6 IGHMBP2 RHOBTB2 MFN2 MACF1 GNA12 GNAS ATP2B1 DNAH9	5.56e-04	839	164	17	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	PMS2 EIF4A3 WRN PSMC4 CHD1 UPF1 BCS1L HSPA13 ABCA6 IGHMBP2 RHOBTB2 MFN2 MACF1 GNA12 GNAS ATP2B1 DNAH9	5.64e-04	840	164	17	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	PMS2 EIF4A3 WRN PSMC4 CHD1 UPF1 BCS1L HSPA13 ABCA6 IGHMBP2 RHOBTB2 MFN2 MACF1 GNA12 GNAS ATP2B1 DNAH9	5.64e-04	840	164	17	GO:0016818
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	PMS2 WRN CHD1 UPF1 IGHMBP2 SMARCA1	6.39e-04	127	164	6	GO:0008094
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CTU2 TRIO RPS6KA5 PARP8 STK32B ELP1 MAGI3 RYK PAPOLG JAK2 MAPK15 PIK3C2B PIK3C2G STRADA PKLR KDR WNK3 MAP3K2	7.20e-04	938	164	18	GO:0016772
GeneOntologyMolecularFunction	methylation-dependent protein binding	CHD1 ZZEF1 PWWP2A GLYR1 L3MBTL3	7.95e-04	88	164	5	GO:0140034
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	PMS2 ALKBH2 EIF4A3 WRN GATB MUS81 DARS1 CHD1 UPF1 SARS1 IGHMBP2 SMARCA1 RARS2 ZC3H12C	9.01e-04	645	164	14	GO:0140640
GeneOntologyMolecularFunction	1-phosphatidylinositol-4-phosphate 3-kinase activity	PIK3C2B PIK3C2G	1.37e-03	7	164	2	GO:0035005
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	PMS2 ALKBH2 WRN MUS81 CHD1 UPF1 IGHMBP2 SMARCA1	1.48e-03	262	164	8	GO:0140097
GeneOntologyMolecularFunction	dynein light intermediate chain binding	CCDC88A DNAH17 DNAH9	1.53e-03	28	164	3	GO:0051959
GeneOntologyMolecularFunction	kinase activity	TRIO RPS6KA5 STK32B ELP1 MAGI3 RYK JAK2 MAPK15 PIK3C2B PIK3C2G STRADA PKLR KDR WNK3 MAP3K2	1.61e-03	764	164	15	GO:0016301
GeneOntologyMolecularFunction	helicase activity	EIF4A3 WRN CHD1 UPF1 IGHMBP2 SMARCA1	1.97e-03	158	164	6	GO:0004386
GeneOntologyBiologicalProcess	neuronal ion channel clustering	GLDN ANK3 SCLT1 CNTN2	8.26e-06	17	163	4	GO:0045161
GeneOntologyBiologicalProcess	clustering of voltage-gated sodium channels	GLDN ANK3 SCLT1	2.64e-05	8	163	3	GO:0045162
GeneOntologyBiologicalProcess	regulation of anatomical structure size	DOCK4 COL6A1 CARMIL2 HTR2C SPTA1 RYK MSN TLR2 MFN2 MACF1 KDR ATP2B1 ALOX5 VAV1 WNK3 CNTN2	3.28e-05	618	163	16	GO:0090066
GeneOntologyCellularComponent	cytoplasmic side of plasma membrane	MYH10 CARMIL2 SPTA1 MSN JAK2 GNA12 GNAS MCF2L ATP2B1	1.38e-05	185	161	9	GO:0009898
GeneOntologyCellularComponent	COPI-coated Golgi to ER transport vesicle	CCDC88A GNAS	5.90e-05	2	161	2	GO:0030142
GeneOntologyCellularComponent	extrinsic component of cytoplasmic side of plasma membrane	CARMIL2 JAK2 GNA12 GNAS MCF2L	7.08e-05	56	161	5	GO:0031234
GeneOntologyCellularComponent	cytoplasmic side of membrane	MYH10 CARMIL2 SPTA1 MSN JAK2 GNA12 GNAS MCF2L ATP2B1	7.58e-05	230	161	9	GO:0098562
GeneOntologyCellularComponent	sarcolemma	COL6A1 COL6A3 ANK3 CAPN3 LAMA2 MSN GNAS ALOX5	1.15e-04	190	161	8	GO:0042383
GeneOntologyCellularComponent	collagen type VI trimer	COL6A1 COL6A3	1.76e-04	3	161	2	GO:0005589
GeneOntologyCellularComponent	collagen beaded filament	COL6A1 COL6A3	1.76e-04	3	161	2	GO:0098647
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	TNC LAMA2 PLAU	2.82e-04	17	161	3	GO:0098637
GeneOntologyCellularComponent	extrinsic component of membrane	CARMIL2 TRIO JAK2 PIK3C2B PIK3C2G GNA12 GNAS MCF2L	4.22e-04	230	161	8	GO:0019898
GeneOntologyCellularComponent	collagen trimer	COL6A1 COL6A3 GLDN COL12A1 COL6A6	5.96e-04	88	161	5	GO:0005581
GeneOntologyCellularComponent	tight junction	ANK3 CYTH3 SIPA1L3 MAGI3 MAPK15 WNK3	7.35e-04	139	161	6	GO:0070160
GeneOntologyCellularComponent	presynaptic active zone	TRIO IQSEC2 ZZEF1 RYK NPTN ATP2B1	7.92e-04	141	161	6	GO:0048786
GeneOntologyCellularComponent	elongator holoenzyme complex	ELP1 ELP2	8.67e-04	6	161	2	GO:0033588
GeneOntologyCellularComponent	proteasome accessory complex	PSMC4 PSMD12 PSME2	9.11e-04	25	161	3	GO:0022624
HumanPheno	Curved toe phalanx	COL6A1 COL6A3 COL12A1	1.03e-05	4	71	3	HP:0010176
HumanPheno	Reduced muscle collagen VI	COL6A1 COL6A3 COL12A1	1.03e-05	4	71	3	HP:0030095
HumanPheno	Reduced maximal expiratory pressure	COL6A1 COL6A3 COL12A1	1.03e-05	4	71	3	HP:0012497
HumanPheno	Quadriceps muscle weakness	COL6A1 COL6A3 COL12A1 RRM2B MFN2	1.26e-05	23	71	5	HP:0003731
HumanPheno	Increased laxity of fingers	COL6A1 COL6A3 COL12A1	2.54e-05	5	71	3	HP:0006149
HumanPheno	Diaphragmatic weakness	COL6A1 COL6A3 COL12A1 IGHMBP2	7.19e-05	17	71	4	HP:0009113
HumanPheno	Wrist hypermobility	COL6A1 COL6A3 COL12A1	8.73e-05	7	71	3	HP:0005072
HumanPheno	Dimple chin	CTU2 KMT2D PIEZO2 NALCN	9.15e-05	18	71	4	HP:0010751
HumanPheno	Elbow contracture	COL6A1 COL6A3 GLDN COL12A1 CAPN3 LAMA2 NALCN RARS2	1.18e-04	109	71	8	HP:0034391
HumanPheno	Difficulty climbing stairs	COL6A1 COL12A1 RRM2B CAPN3 LAMA2 GFPT1 MFN2	1.70e-04	86	71	7	HP:0003551
HumanPheno	Flexion contracture of finger	COL6A1 COL6A3 GLDN COL12A1 NUP107 CAPN3 PHF6 XYLT1 PIEZO2 NALCN IGHMBP2 SPEN	1.87e-04	257	71	12	HP:0012785
HumanPheno	Finger joint contracture	COL6A1 COL6A3 GLDN COL12A1 NUP107 CAPN3 PHF6 XYLT1 PIEZO2 NALCN IGHMBP2 SPEN	2.01e-04	259	71	12	HP:0034681
HumanPheno	Distal joint hypermobility	COL6A1 COL6A3 COL12A1	2.05e-04	9	71	3	HP:0020152
Domain	Spectrin	TRIO SPTA1 MACF1 MCF2L	4.15e-05	23	161	4	PF00435
Domain	Spectrin_repeat	TRIO SPTA1 MACF1 MCF2L	1.07e-04	29	161	4	IPR002017
Domain	VWA	COL6A1 COL6A3 COL12A1 COL6A6 MATN2	1.20e-04	56	161	5	PF00092
Domain	P-loop_NTPase	MYH10 EIF4A3 WRN PSMC4 MAGI3 CHD1 UPF1 BCS1L GIMAP8 ABCA6 IGHMBP2 RHOBTB2 SMARCA1 MFN2 GNA12 GNAS PARPBP HS6ST3 DNAH9	1.32e-04	848	161	19	IPR027417
Domain	SPEC	TRIO SPTA1 MACF1 MCF2L	1.58e-04	32	161	4	SM00150
Domain	Spectrin/alpha-actinin	TRIO SPTA1 MACF1 MCF2L	1.58e-04	32	161	4	IPR018159
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL6A1 COL6A3 COL6A6 RPS6KA5 SPTA1	2.61e-05	38	132	5	MM14969
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL6A1 COL6A3 COL6A6 RPS6KA5 SPTA1 CNTN2	2.64e-05	63	132	6	M11187
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	CTU2 MYH10 COL12A1 HYOU1 AKAP17A TRIO EIF4A3 UBR4 USP24 PHF6 PSMC4 TOMM20 PSMD12 PSME2 XPO1 GFPT1 HSPA13 GMPS FASN PTPA TBC1D4 EIF4B MFN2 PDCD11 MACF1 CCAR2 ATG9A GNAS PGM2 RBM17	5.16e-13	1297	164	30	33545068
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	GPD2 PMS2 MYH10 HYOU1 ANK3 NUP107 TRIO DUSP2 SIPA1L3 ELP1 PSMC4 PSMD12 XPO1 HUWE1 GMPS PPP4R3B PTPA KMT2D CCDC88A TBC1D4 PTPRZ1 GLYR1 CCAR2 ELP2 L3MBTL3 ATP2B1	4.83e-12	1049	164	26	27880917
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYH10 HYOU1 NUP107 UBR4 USP24 ELP1 CHD1 PSMD12 UPF1 XPO1 HUWE1 RBM28 GFPT1 MSN GMPS FASN GLYR1 PDCD11 MACF1 CCAR2 SPEN	5.53e-12	653	164	21	22586326
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	MYH10 HYOU1 NUP107 EIF4A3 UBR4 USP24 PHF6 ELP1 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 GMPS FASN TBC1D4 SARS1 PDCD11 CCAR2	2.89e-11	638	164	20	33239621
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GPD2 MYH10 HYOU1 NUP107 TRIO EIF4A3 UBR4 PHF6 ELP1 PSMC4 DARS1 CHD1 PSMD12 UPF1 XPO1 HUWE1 GFPT1 FASN MAPK15 SARS1 GLYR1 SMARCA1 PDCD11 CCAR2 GNAS SPEN ATP2B1	7.33e-10	1425	164	27	30948266
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYH10 NUP107 EIF4A3 UBR4 PHF6 ELP1 PSMC4 DARS1 CHD1 UPF1 XPO1 HUWE1 RBM28 GFPT1 AAR2 MSN GMPS FASN TBC1D4 GLYR1 SMARCA1 PDCD11 AP1G2 MACF1 CCAR2 ATP2B1	1.17e-09	1353	164	26	29467282
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	GPD2 HYOU1 ANK3 USP24 ARHGEF12 PSMC4 MAGI3 DARS1 PSMD12 UPF1 XPO1 GFPT1 MSN GMPS FASN CCDC88A EIF4B MACF1 ATP2B1	1.24e-09	708	164	19	39231216
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	HYOU1 NUP107 EIF4A3 UBR4 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 GFPT1 FASN TBC1D4 GLYR1 GNAS ATP2B1	5.82e-09	534	164	16	35032548
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	GPD2 MYH10 HYOU1 ANK3 EIF4A3 SPTA1 UBR4 PSMC4 DARS1 PSMD12 UPF1 HUWE1 ZZEF1 GFPT1 FASN PTPA MACF1 GNAS PGM2	1.03e-08	807	164	19	30575818
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	COL6A3 MYH10 HYOU1 ELP1 UPF1 XPO1 GMPS FASN EIF4B PKLR	1.50e-08	179	164	10	36261009
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 NUP107 ZNF180 ELP1 PSMC4 HUWE1 PAPOLG PPP4R3B CCDC88A TBC1D4 PIK3C2B MACF1 GNAS SPEN TRIM37 PML	2.23e-08	588	164	16	38580884
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	NIBAN1 HYOU1 EIF4A3 UBR4 USP24 ELP1 PSMC4 DARS1 PSMD12 PSME2 XPO1 HUWE1 ZZEF1 GFPT1 NCS1 MSN GMPS PPP4R3B FASN TBC1D4 SARS1 EIF4B MACF1 CCAR2 ELP2	2.32e-08	1455	164	25	22863883
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MYH10 WWC3 NUP107 EIF4A3 MATN2 SIPA1L3 PHF6 PSMC4 DARS1 PSMD12 UPF1 PSME2 XPO1 HUWE1 GFPT1 GMPS FASN TBC1D4 SARS1 IGHMBP2 EIF4B GNAS RBM17	2.51e-08	1247	164	23	27684187
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	GPD2 MYH10 HYOU1 EIF4A3 UBR4 USP24 ELP1 PSMC4 DARS1 CHD1 UPF1 PSME2 XPO1 HUWE1 GFPT1 AAR2 MSN GMPS FASN TBC1D4 SARS1 EIF4B MACF1 CCAR2	5.83e-08	1415	164	24	28515276
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	MYH10 EIF4A3 UBR4 PSMC4 DARS1 UPF1 HUWE1 RBM28 FASN CCDC88A GLYR1 EIF4B CCAR2 PML RBM17	6.24e-08	551	164	15	34728620
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	HYOU1 EIF4A3 PHF6 PSMC4 DARS1 PSMD12 UPF1 PSME2 XPO1 RBM28 MSN GMPS PPP4R3B FASN KMT2D EIF4B CCAR2 SPEN L3MBTL3 PML RBM17	6.32e-08	1103	164	21	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TBC1D9B TRIO CYTH3 SIPA1L3 UBR4 MUS81 HUWE1 ZZEF1 JAK2 FASN KMT2D PIK3C2B CSAD MFN2 PDCD11 AP1G2 GNA12 ATG9A MCF2L SPEN ALOX5	6.52e-08	1105	164	21	35748872
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPD2 MYH10 CARMIL2 HYOU1 ANK3 TRIO TNC SPTA1 SIPA1L3 IQSEC2 ARHGEF12 ELP1 DARS1 UPF1 XPO1 NPTN FASN SARS1 MTERF2 PTPRZ1 EIF4B MACF1 ATP2B1 CNTN2	7.18e-08	1431	164	24	37142655
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 MYH10 ARHGEF12 PHF6 KLHL29 RHOBTB2 MFN2 MACF1 CCAR2 MCF2L SPEN TET3 PLCE1	7.93e-08	407	164	13	12693553
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH10 HYOU1 EIF4A3 SPTA1 PARP8 SIPA1L3 UBR4 GATB MAGI3 TOMM20 RNF17 AAR2 MSN FASN EIF4B SMARCA1 MACF1 ATG4C CCAR2 KDR GNA12 MCF2L SPEN ATP2B1	8.27e-08	1442	164	24	35575683
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	MYH10 HYOU1 UBR4 PSMC4 PSMD12 UPF1 PSME2 XPO1 HUWE1 GFPT1 GMPS SARS1 SMARCA1 CCAR2 GNAS SPEN	1.20e-07	665	164	16	30457570
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	GPD2 MYH10 HYOU1 RRM2B UBR4 BDH2 PHF6 PSMC4 DARS1 PSMD12 UPF1 PSME2 XPO1 HUWE1 GFPT1 MSN GMPS FASN FCGBP EIF4B PDCD11 GNAS RBM17	1.31e-07	1367	164	23	32687490
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 CARMIL2 TRIO PARP8 SIPA1L3 IQSEC2 MAGI3 LARP1B CCDC88A TBC1D4 PIK3C2B EIF4B MACF1 GNAS ATP2B1 WNK3 MAP3K2 PML	1.52e-07	861	164	18	36931259
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	COL6A3 MYH10 CHD1 PSMD12 LARP1B EIF4B CCAR2 GNA12 GNAS HS6ST3	1.65e-07	231	164	10	36597993
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	EIF4A3 ARHGEF12 PHF6 PSMC4 DARS1 PSMD12 UPF1 PSME2 HUWE1 RBM28 LARP1B AAR2 FASN CSAD EIF4B PDCD11 GNAS ATP2B1 RBM17	1.86e-07	971	164	19	33306668
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	MYH10 HYOU1 KMT5A UBR4 PSMC4 UPF1 XPO1 HUWE1 FASN	2.28e-07	182	164	9	31067453
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	B3GALNT1 MYH10 HYOU1 ANK3 SPTA1 UBR4 PSMD12 UPF1 GFPT1 SARS1 PKLR	2.39e-07	304	164	11	32235678
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	HYOU1 AKAP17A EIF4A3 UBR4 PSMC4 DARS1 PSMD12 UPF1 PSME2 XPO1 GFPT1 FASN KMT2D SARS1 PDCD11 MACF1	2.94e-07	711	164	16	33022573
Pubmed	Subtractive hybridisation screen identifies sexually dimorphic gene expression in the embryonic mouse gonad.	CTU2 WRN PSMC4 MSN GNAS RBM17	2.98e-07	57	164	6	14595844
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GPD2 NIBAN1 HYOU1 NUP107 EIF4A3 ELP1 DARS1 CHD1 XPO1 HUWE1 RBM28 FASN PDCD11 MACF1 CCAR2 GNAS SPEN ATP2B1 RBM17	4.16e-07	1024	164	19	24711643
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DOCK4 MYH10 ANK3 TRIO IQSEC2 UBR4 USP24 PSMC4 DARS1 PSMD12 HUWE1 NCS1 MSN GMPS CCDC88A GLYR1 IGHMBP2 EIF4B MACF1 RBM17	4.79e-07	1139	164	20	36417873
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH10 TBC1D9B HYOU1 UBR4 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 GFPT1 MSN FASN CCAR2 ATP2B1	4.84e-07	647	164	15	26618866
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	NUP107 EIF4A3 USP24 ELP1 PSMC4 PSMD12 UPF1 HUWE1 RNF17 GMPS FASN MACF1 GNAS RBM17	7.68e-07	582	164	14	20467437
Pubmed	Differential and restricted expression of novel collagen VI chains in mouse.	COL6A1 COL6A3 COL6A6	1.02e-06	5	164	3	21477648
Pubmed	Differential expression of phosphacan/RPTPbeta isoforms in the developing mouse visual system.	TNC PTPRZ1 CNTN2	1.02e-06	5	164	3	17722031
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A1 COL6A3 COL6A6	1.02e-06	5	164	3	23869615
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	MYH10 NUP107 UBR4 PHF6 ELP1 DARS1 CHD1 UPF1 RBM28 GFPT1 MSN GLYR1 SMARCA1 MACF1	1.12e-06	601	164	14	33658012
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	MYH10 HYOU1 AKAP17A EIF4A3 UBR4 WRN USP24 PHF6 PSMC4 DARS1 CHD1 PSMD12 UPF1 HUWE1 RBM28 GMPS PPP4R3B FASN PKLR PDCD11 CCAR2	1.16e-06	1318	164	21	30463901
Pubmed	Global landscape of HIV-human protein complexes.	HYOU1 UBR4 ARHGEF12 DARS1 XPO1 HUWE1 HSPA13 MSN SARS1 CCAR2 ATP2B1 RBM17	1.99e-06	457	164	12	22190034
Pubmed	A protein interaction landscape of breast cancer.	DOCK4 PMS2 MYH10 HYOU1 ANK3 TRIO SIPA1L3 UBR4 DARS1 RBM28 SARS1 STRADA PDCD11 MACF1	2.09e-06	634	164	14	34591612
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	HYOU1 ANK3 NUP107 UBR4 GATB ELP1 PSMC4 CHD1 UPF1 RBM28 BCS1L AAR2 HSPA13 CCDC88A SARS1 GLYR1 PDCD11 MACF1 ELP2 GNAS ATP2B1 PML	2.12e-06	1487	164	22	33957083
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MYH10 HYOU1 EIF4A3 SIPA1L3 PHF6 DARS1 UPF1 XPO1 RBM28 GFPT1 AAR2 MSN FASN GLYR1 EIF4B SMARCA1 PDCD11 GNAS SPEN PML	2.17e-06	1257	164	20	36526897
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYH10 HYOU1 ANK3 UBR4 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 MSN GMPS FASN TBC1D4 SARS1 EIF4B MACF1 CCAR2 GNAS	2.28e-06	1149	164	19	35446349
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	NUP107 UBR4 ELP1 PSMC4 DARS1 PSMD12 XPO1 HUWE1 ZZEF1 AAR2 FASN EIF4B RARS2 ATG9A	3.15e-06	657	164	14	36180527
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	UBR4 PSMC4 DARS1 PSMD12 XPO1 HUWE1 GMPS FASN CCDC88A CCAR2 ATP2B1	3.38e-06	399	164	11	37536630
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYH10 ANK3 TRIO CYTH3 SIPA1L3 IQSEC2 UBR4 ARHGEF12 UPF1 HUWE1 MSN NPTN CCDC88A MFN2 MACF1 CCAR2 WNK3	3.42e-06	963	164	17	28671696
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	AKAP17A EIF4A3 WRN PHF6 DARS1 UPF1 XPO1 RBM28 GLYR1 IGHMBP2 PDCD11 MACF1 CCAR2 L3MBTL3 RBM17	3.46e-06	759	164	15	35915203
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	NUP107 PSMC4 DARS1 PSME2 XPO1 HUWE1 GMPS FASN CCDC88A TBC1D4 EIF4B ELP2 GNAS	3.52e-06	571	164	13	37167062
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A1 COL6A3 COL6A6	3.55e-06	7	164	3	18400749
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A1 COL6A3 COL6A6	3.55e-06	7	164	3	18276594
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	MYH10 HYOU1 NUP107 EIF4A3 DARS1 UPF1 XPO1 RBM28 FASN PDCD11 ATG9A GNAS	3.58e-06	484	164	12	31995728
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL6A1 COL6A3 COL12A1 COL6A6 TNC MATN2 LAMA2	3.80e-06	135	164	7	28675934
Pubmed	Phosphoinositide 3-kinase-dependent inhibition of dendritic cell interleukin-12 production by Giardia lamblia.	PIK3C2B PIK3C2G TLR2 TLR3	3.94e-06	23	164	4	19047410
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	HYOU1 DUSP2 UBR4 ELP1 PSMC4 CHD1 PSMD12 XPO1 HUWE1 RBM28 GFPT1 AAR2 GMPS FASN CCAR2 GNAS ATP2B1	3.97e-06	974	164	17	28675297
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	NUP107 UBR4 PSMC4 DARS1 UPF1 XPO1 HUWE1 FASN SARS1 CCAR2	4.40e-06	332	164	10	32786267
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	GPD2 MYH10 TBC1D9B HYOU1 UBR4 ELP1 PSMC4 PSMD12 UPF1 PSME2 XPO1 HUWE1 RBM28 FASN PDCD11 CCAR2 RARS2 GNAS ATP2B1 PML RBM17	4.61e-06	1440	164	21	30833792
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	GPD2 MYH10 EIF4A3 PHF6 PSMC4 CHD1 XPO1 HUWE1 RBM28 RYK PAPOLG FASN GLYR1 EIF4B PDCD11 CCAR2 PML	4.85e-06	989	164	17	36424410
Pubmed	Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.	MYH10 PSMD12 BCS1L FASN CCDC88A GIMAP8 GNAS PLCE1	5.47e-06	201	164	8	25192599
Pubmed	Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.	RBFOX3 TNC LAMA2 PTPRZ1	5.58e-06	25	164	4	19373938
Pubmed	A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.	COL6A1 COL6A3 COL6A6	5.67e-06	8	164	3	24563484
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	COL6A1 COL6A3 COL12A1 TNC MATN2 LAMA2 PODN	6.38e-06	146	164	7	27068509
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	EIF4A3 UBR4 ELP1 PSMC4 TOMM20 DARS1 PSMD12 UPF1 HUWE1 GFPT1 FASN SMARCA1 PDCD11 ELP2	6.92e-06	704	164	14	29955894
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	HYOU1 TRIO SIPA1L3 UBR4 USP24 ELP1 CHD1 ZZEF1	8.08e-06	212	164	8	33853758
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	HYOU1 EIF4A3 SIPA1L3 PSMC4 PSMD12 UPF1 XPO1 LARP1B MSN GMPS FASN EIF4B TLR3 CCAR2	8.11e-06	714	164	14	28302793
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	NUP107 EIF4A3 UBR4 ELP1 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 GFPT1 AAR2 GMPS FASN MFN2 CCAR2 RARS2 ELP2 GNAS	8.23e-06	1257	164	19	37317656
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	GPD2 MYH10 RBFOX3 HYOU1 NUP107 UBR4 GATB ELP1 PSMC4 UPF1 HUWE1 RBM28 LARP1B ZZEF1 BCS1L SARS1 MFN2 PDCD11 CCAR2 RARS2 GNAS	8.24e-06	1496	164	21	32877691
Pubmed	Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin Signaling.	TOMM20 HUWE1 MFN2	8.47e-06	9	164	3	28943312
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYH10 TRIO EIF4A3 DARS1 UPF1 HUWE1 RNF17 NCS1 MACF1 ATP2B1	8.50e-06	358	164	10	32460013
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL6A1 COL6A3 COL12A1 COL6A6 TNC MATN2 LAMA2	8.67e-06	153	164	7	25037231
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COL6A1 COL6A3 COL12A1 TNC MATN2 PODN	8.78e-06	101	164	6	20551380
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ANK3 RRM2B SIPA1L3 UBR4 ARHGEF12 PHF6 EIF4B MACF1 SPEN DNAH9	9.14e-06	361	164	10	26167880
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	MYH10 HYOU1 PSMC4 DARS1 CHD1 PSMD12 PSME2 MSN TBC1D4 SARS1 EIF4B MACF1	1.04e-05	538	164	12	28524877
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TBC1D9B HYOU1 NUP107 UBR4 USP24 ELP1 PSMC4 UPF1 XPO1 HUWE1 GFPT1 AAR2 NPTN FASN SARS1 WNK3	1.08e-05	942	164	16	31073040
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	UBR4 ELP1 UPF1 XPO1 HUWE1 RBM28 FASN PDCD11	1.09e-05	221	164	8	29991511
Pubmed	Defining the membrane proteome of NK cells.	NIBAN1 CARMIL2 HYOU1 NUP107 EIF4A3 UBR4 PSMC4 DARS1 PSMD12 PSME2 XPO1 HUWE1 PAPOLG FASN IGHMBP2 ATG9A GNAS ATP2B1	1.12e-05	1168	164	18	19946888
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	IQSEC2 UBR4 MAGI3 HUWE1 RBM28 ZZEF1 GFPT1 GMPS JAK2 TBC1D4 GIMAP8 SARS1 TLR3 ALOX5	1.14e-05	736	164	14	29676528
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	MYH10 AKAP17A EIF4A3 MATN2 PHF6 DARS1 UPF1 RBM28 GFPT1 MSN FASN GLYR1 EIF4B PDCD11 GNAS RBM17	1.19e-05	949	164	16	36574265
Pubmed	Isolation of tyrosine kinase related genes expressed in the early hematopoietic system.	RYK JAK2 KDR	1.21e-05	10	164	3	8034026
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL6A1 COL6A3 TNC MATN2 LAMA2	1.34e-05	64	164	5	22261194
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MYH10 NUP107 UBR4 DARS1 HUWE1 XYLT1 FASN KMT2D TBC1D4 GLYR1 SMARCA1 CCAR2 SPEN L3MBTL3 ATP2B1	1.46e-05	857	164	15	25609649
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	DOCK4 MYH10 PSMC4 DARS1 UPF1 XPO1 FASN EIF4B RARS2 RBM17	1.52e-05	383	164	10	29331416
Pubmed	Murine txk: a protein tyrosine kinase gene regulated by T cell activation.	RYK JAK2 KDR PGM2	1.55e-05	32	164	4	7542761
Pubmed	Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.	NUP107 PSMC4 XPO1 HUWE1 ATP2B1	1.67e-05	67	164	5	29357390
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CABLES2 RBFOX3 TRIO RPS6KA5 UBR4 USP24 ARHGEF12 MAGI3 UPF1 MSN MCF2L	1.73e-05	475	164	11	31040226
Pubmed	Discovery and validation of genes driving drug-intake and related behavioral traits in mice.	MYH10 PARP8 GIPC3 HSPB2	1.75e-05	33	164	4	38164795
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	HYOU1 EIF4A3 PHF6 ELP1 PSMC4 DARS1 PSMD12 UPF1 PSME2 XPO1 HUWE1 AAR2 GMPS FASN TBC1D4 EIF4B SMARCA1 CCAR2 GNAS	1.90e-05	1335	164	19	29229926
Pubmed	Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.	PSMC4 PSMD12 FASN GNA12 GNAS	2.07e-05	70	164	5	21726808
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL6A1 COL6A3 COL12A1 COL6A6 TNC MATN2 LAMA2	2.07e-05	175	164	7	28071719
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	MYH10 SIPA1L3 DARS1 CHD1 XPO1 GNAS	2.14e-05	118	164	6	27377895
Pubmed	Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.	PIK3C2B PIK3C2G KDR	2.20e-05	12	164	3	14602571
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	GPD2 NIBAN1 HYOU1 GATB PHF6 PSMD12 HUWE1 GMPS CCAR2 ATG9A	2.21e-05	400	164	10	35013556
Pubmed	Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis.	TLR2 TLR3	2.21e-05	2	164	2	21960283
Pubmed	Strong association of TLR2 and TLR3 polymorphisms with keratoacanthoma and common warts: a case-control study.	TLR2 TLR3	2.21e-05	2	164	2	38868969
Pubmed	G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.	GNA12 GNAS	2.21e-05	2	164	2	21308712
Pubmed	Type VI collagen and its cleavage product, endotrophin, cooperatively regulate the adipogenic and lipolytic capacity of adipocytes.	COL6A1 COL6A3	2.21e-05	2	164	2	33188786
Pubmed	PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.	TNFSF10 PML	2.21e-05	2	164	2	15459016
Pubmed	Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis?	TLR2 TLR3	2.21e-05	2	164	2	16035096
Pubmed	DBC2, a candidate for a tumor suppressor gene involved in breast cancer.	RHOBTB2 CCAR2	2.21e-05	2	164	2	12370419
Pubmed	Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells.	TNFSF10 PLAU	2.21e-05	2	164	2	24481457
Pubmed	Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to control Schistosoma mansoni infection and pathology.	TLR2 TLR3	2.21e-05	2	164	2	18023390
Interaction	CHEK2 interactions	MYH10 SIPA1L3 UBR4 WRN MUS81 DARS1 RBM28 FASN KMT2D RHOBTB2 TLR3 CCAR2 GNAS CNTN2 PML	1.95e-09	250	163	15	int:CHEK2
Interaction	SIRT7 interactions	MYH10 HYOU1 NUP107 UBR4 USP24 ELP1 CHD1 PSMD12 UPF1 PSME2 XPO1 HUWE1 RBM28 GFPT1 MSN GMPS FASN GLYR1 PDCD11 MACF1 CCAR2 SPEN	1.54e-07	744	163	22	int:SIRT7
Interaction	KCNA3 interactions	GPD2 HYOU1 ANK3 USP24 ARHGEF12 PSMC4 MAGI3 DARS1 PSMD12 UPF1 XPO1 GFPT1 MSN PAPOLG GMPS FASN CCDC88A TBC1D4 EIF4B TLR3 MACF1 SPEN ATP2B1	5.76e-07	871	163	23	int:KCNA3
Interaction	STIP1 interactions	MYH10 HYOU1 NUP107 EIF4A3 UBR4 USP24 PHF6 ELP1 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 AAR2 MSN GMPS FASN TBC1D4 MAPK15 SARS1 MFN2 PDCD11 CCAR2	1.92e-06	1006	163	24	int:STIP1
Interaction	NPM1 interactions	DOCK4 NIBAN1 PMS2 MYH10 ANK3 MATN2 PHF6 MUS81 PSMC4 CHD1 PSMD12 XPO1 HUWE1 RBM28 RYK AAR2 MSN PAPOLG FASN PTPA GLYR1 CENPI PDCD11 KDR TRIM37 PML	4.08e-06	1201	163	26	int:NPM1
Interaction	STAT1 interactions	DOCK4 COL6A1 RPS6KA5 DUSP2 XPO1 HUWE1 MSN JAK2 PTPA SARS1 KDR ELP2 PML	4.42e-06	342	163	13	int:STAT1
Interaction	AHCY interactions	DARS1 PSMD12 UPF1 XPO1 HUWE1 AAR2 HSPA13 MSN GMPS FASN EIF4B PML	4.91e-06	293	163	12	int:AHCY
Interaction	ATXN1 interactions	GPD2 MYH10 TBC1D9B HYOU1 MATN2 DUSP2 UBR4 PSMC4 TOMM20 PSMD12 UPF1 PSME2 XPO1 HUWE1 GFPT1 GMPS SARS1 SMARCA1 CCAR2 GNAS SPEN TRIM37 PML	1.10e-05	1039	163	23	int:ATXN1
Interaction	EED interactions	MYH10 TBC1D9B HYOU1 NUP107 TRIO EIF4A3 KMT5A UBR4 ELP1 PSMC4 TOMM20 DARS1 PSMD12 UPF1 XPO1 HUWE1 RBM28 GFPT1 GMPS PWWP2A FASN GLYR1 SMARCA1 PDCD11 MACF1 CCAR2 SPEN VAV1	1.34e-05	1445	163	28	int:EED
Interaction	HERC2 interactions	MYH10 AKAP17A EIF4A3 UBR4 WRN ARHGEF12 MUS81 PSMC4 UPF1 XPO1 KMT2D CCDC88A GLYR1 MACF1 GNAS	1.50e-05	503	163	15	int:HERC2
Interaction	TOP3B interactions	MYH10 TBC1D9B HYOU1 TRIO CYTH3 RRM2B SIPA1L3 UBR4 WRN MUS81 DARS1 UPF1 HUWE1 ZZEF1 JAK2 FASN KMT2D PIK3C2B CSAD MFN2 PDCD11 AP1G2 GNA12 ATG9A GNAS MCF2L SPEN ALOX5	1.83e-05	1470	163	28	int:TOP3B
Interaction	CFTR interactions	SPEF1 MYH10 TBC1D9B HYOU1 TNFSF10 TNC UBR4 BDH2 PSMC4 TOMM20 DARS1 PSMD12 UPF1 PSME2 XPO1 HUWE1 GFPT1 RYK MSN FASN STRADA TLR3 MACF1 CCAR2 GNAS ATP2B1 VAV1 HSPB2	2.07e-05	1480	163	28	int:CFTR
Interaction	CEBPA interactions	HYOU1 NUP107 EIF4A3 PHF6 PSMC4 DARS1 CHD1 PSMD12 UPF1 PSME2 XPO1 RBM28 MSN GMPS PPP4R3B FASN KMT2D EIF4B PDCD11 MACF1 CCAR2 SPEN L3MBTL3 PML RBM17	2.30e-05	1245	163	25	int:CEBPA
Interaction	PSMC6 interactions	PMS2 MYH10 UBR4 GATB PSMC4 PSMD12 PSME2 HUWE1 MSN MFN2 CCAR2 PML	2.31e-05	342	163	12	int:PSMC6
Interaction	PSMC3 interactions	PMS2 MYH10 CAPN3 PSMC4 PSMD12 PSME2 HUWE1 AAR2 MSN FASN MFN2 CCAR2 PML	4.38e-05	425	163	13	int:PSMC3
Interaction	COLGALT1 interactions	RPS6KA5 DARS1 UPF1 XPO1 HSPA13 GMPS FASN PML	4.44e-05	158	163	8	int:COLGALT1
Interaction	IPO11 interactions	HTR2C EIF4A3 XPO1 HUWE1 AAR2 NPTN RHOBTB2 KDR	4.65e-05	159	163	8	int:IPO11
Interaction	CALM2 interactions	IQSEC2 UBR4 ARHGEF12 TBC1D4 RHOBTB2 SCLT1 ATP2B1 TRIM37 PML	4.71e-05	206	163	9	int:CALM2
Interaction	CALM1 interactions	HTR2C IQSEC2 UBR4 ARHGEF12 MUS81 PSMD12 HUWE1 GLP2R AAR2 JAK2 CCDC88A TBC1D4 GNAS SCLT1 ATP2B1 PML	5.03e-05	626	163	16	int:CALM1
Interaction	PSMD2 interactions	PSMC4 PSMD12 PSME2 HUWE1 GFPT1 AAR2 FASN EIF4B MFN2 ATG4C CCAR2 VAV1 PML	5.55e-05	435	163	13	int:PSMD2
Interaction	YWHAZ interactions	MYH10 CARMIL2 NUP107 COL6A6 RPS6KA5 SPTA1 PARP8 SIPA1L3 IQSEC2 XPO1 HUWE1 NCS1 AAR2 MSN CCDC88A TBC1D4 PIK3C2B EIF4B MACF1 CCAR2 ATG9A ATP2B1 TRIM37 MAP3K2 PML	5.92e-05	1319	163	25	int:YWHAZ
Interaction	NBR1 interactions	CTU2 UBR4 USP24 PSMD12 PSME2 GMPS FASN PTPA MFN2 MACF1 ATG9A TRIM37	6.41e-05	380	163	12	int:NBR1
Interaction	CDC5L interactions	NUP107 TRIO EIF4A3 WRN USP24 ELP1 PSMC4 PSMD12 UPF1 HUWE1 RNF17 AAR2 GMPS FASN MACF1 GNAS SPEN PML RBM17	6.47e-05	855	163	19	int:CDC5L
Interaction	CTNNB1 interactions	MYH10 ANK3 EIF4A3 SIPA1L3 MAGI3 DARS1 XPO1 HUWE1 GFPT1 RYK MSN PTPA KMT2D CCDC88A MTERF2 PTPRZ1 KDR TRIM37 MAP3K2 PML RBM17	6.68e-05	1009	163	21	int:CTNNB1
Interaction	YWHAG interactions	DOCK4 MYH10 CARMIL2 AKAP17A PARP8 SIPA1L3 IQSEC2 USP24 MAGI3 XPO1 HUWE1 LARP1B NCS1 AAR2 JAK2 CCDC88A TBC1D4 PIK3C2B EIF4B MACF1 KDR ATG9A GNAS MAP3K2	6.76e-05	1248	163	24	int:YWHAG
Interaction	BIRC3 interactions	GPD2 HYOU1 NUP107 TRIO EIF4A3 UBR4 PHF6 PSMC4 DARS1 CHD1 PSMD12 UPF1 XPO1 HUWE1 GFPT1 FASN MAPK15 SARS1 GLYR1 TLR3 PDCD11 CCAR2 GNAS SPEN ATP2B1	7.10e-05	1334	163	25	int:BIRC3
Interaction	GSK3B interactions	GPD2 TRIO SIPA1L3 ARHGEF12 XPO1 RBM28 LARP1B GFPT1 MSN GMPS FASN PTPA CCDC88A TBC1D4 CSAD TLR3 PDCD11 MACF1 MAP3K2	7.90e-05	868	163	19	int:GSK3B
Interaction	PSME1 interactions	MYH10 PSMC4 PSMD12 PSME2 XPO1 HUWE1 AAR2 FASN EIF4B SCLT1	8.13e-05	274	163	10	int:PSME1
Interaction	DRD5 interactions	NCS1 GNA12 GNAS	8.17e-05	11	163	3	int:DRD5
Interaction	TRIM33 interactions	COL6A3 MYH10 HYOU1 ELP1 UPF1 XPO1 GMPS FASN EIF4B PKLR TRIM37 HSPB2 PML	8.36e-05	453	163	13	int:TRIM33
Interaction	PSMC2 interactions	PMS2 ARHGEF12 PSMC4 PSMD12 PSME2 XPO1 HUWE1 GFPT1 AAR2 MFN2 ATG4C CCAR2	8.82e-05	393	163	12	int:PSMC2
Interaction	KIF23 interactions	MYH10 AKAP17A EIF4A3 MATN2 LAMA2 CHD1 PSMD12 UPF1 XPO1 HUWE1 LARP1B GFPT1 FASN CENPI PKLR PDCD11 MACF1 GNAS SCLT1 TRIM37 RBM17	9.07e-05	1031	163	21	int:KIF23
Interaction	YWHAQ interactions	CARMIL2 NUP107 EIF4A3 SPTA1 PARP8 SIPA1L3 IQSEC2 CAPN3 UPF1 LARP1B AAR2 PPP4R3B FASN CCDC88A TBC1D4 PIK3C2B EIF4B MACF1 CCAR2 ATG9A TRIM37 MAP3K2	1.01e-04	1118	163	22	int:YWHAQ
Interaction	NUP205 interactions	HYOU1 NUP107 DUSP2 TOMM20 XPO1 HUWE1 RHOBTB2 KDR PML	1.29e-04	235	163	9	int:NUP205
Interaction	HECTD1 interactions	CTU2 MYH10 AKAP17A EIF4A3 WRN PHF6 DARS1 PSMD12 UPF1 XPO1 HUWE1 RBM28 GLYR1 IGHMBP2 PDCD11 MACF1 CCAR2 L3MBTL3 ZNF738 RBM17	1.39e-04	984	163	20	int:HECTD1
Interaction	CTSL interactions	HYOU1 RRM2B UBR4 WRN DARS1 HUWE1 CCDC88A PLAU GNAS	1.51e-04	240	163	9	int:CTSL
Interaction	MAP1LC3B interactions	TBC1D9B ANK3 TRIO EIF4A3 PHF6 TOMM20 UPF1 FASN MAPK15 ATG4C ATG9A GNAS PGM2 PML	1.61e-04	551	163	14	int:MAP1LC3B
Interaction	SHC1 interactions	MYH10 SPTA1 ELP1 XPO1 AAR2 JAK2 FASN PIK3C2B KDR SCLT1 VAV1	1.82e-04	362	163	11	int:SHC1
Interaction	BRCA1 interactions	DOCK4 PMS2 MYH10 HYOU1 NUP107 TRIO UBR4 WRN MUS81 PSMC4 DARS1 PSMD12 UPF1 XPO1 HUWE1 RBM28 MSN GMPS JAK2 FASN CENPI CCAR2 PML	1.84e-04	1249	163	23	int:BRCA1
Interaction	FZR1 interactions	EIF4A3 KMT5A RRM2B ARHGEF12 PHF6 PSMC4 DARS1 PSMD12 UPF1 PSME2 XPO1 HUWE1 RBM28 LARP1B AAR2 FASN CSAD EIF4B PDCD11 GNAS ATP2B1 RBM17	1.97e-04	1172	163	22	int:FZR1
Interaction	PSMD13 interactions	RPS6KA5 UBR4 ARHGEF12 PSMC4 PSMD12 PSME2 HUWE1 MSN FASN MFN2	2.00e-04	306	163	10	int:PSMD13
Interaction	AGR2 interactions	GPD2 MYH10 HYOU1 ANK3 EIF4A3 SPTA1 UBR4 PSMC4 DARS1 PSMD12 UPF1 HUWE1 ZZEF1 GFPT1 FASN PTPA MACF1 GNAS PGM2	2.04e-04	934	163	19	int:AGR2
Interaction	HSP90AA1 interactions	COL6A3 COL12A1 KLHL1 RPS6KA5 STK32B UBR4 XPO1 HUWE1 AAR2 KLHL29 JAK2 FASN MAPK15 STRADA RHOBTB2 METTL18 EIF4B CCAR2 KDR GNA12 TRIM37 MAP3K2 PLCE1	2.17e-04	1263	163	23	int:HSP90AA1
Interaction	SNCA interactions	MYH10 NUP107 AKAP17A UBR4 USP24 BDH2 TOMM20 DARS1 XPO1 GFPT1 MSN GMPS FASN EIF4B MACF1 HSPB2	2.36e-04	716	163	16	int:SNCA
Interaction	CYLD interactions	PMS2 MYH10 HYOU1 KMT5A UBR4 ARHGEF12 PSMC4 TOMM20 DARS1 UPF1 XPO1 HUWE1 FASN PTPA PIK3C2B EIF4B CCAR2 RBM17	2.39e-04	868	163	18	int:CYLD
Interaction	SUZ12 interactions	NUP107 EIF4A3 KMT5A CHD1 UPF1 PWWP2A KMT2D GLYR1 SMARCA1 PDCD11 CCAR2 L3MBTL3 TRIM37 VAV1 PML	2.40e-04	644	163	15	int:SUZ12
Interaction	CNTN1 interactions	TNC RYK NPTN PTPRZ1 CNTN2	2.41e-04	69	163	5	int:CNTN1
Interaction	NUP85 interactions	NUP107 ELP1 PSMC4 XPO1 HUWE1 NPTN CENPI	2.83e-04	156	163	7	int:NUP85
Interaction	HSP90AB1 interactions	ANK3 NUP107 UBR4 MAGI3 DARS1 PSMD12 UPF1 XPO1 HUWE1 AAR2 JAK2 FASN MAPK15 RHOBTB2 CCAR2 SPEN TET3 TRIM37 PML	2.88e-04	960	163	19	int:HSP90AB1
Interaction	AAR2 interactions	HYOU1 EIF4A3 UBR4 USP24 ELP1 PSMC4 DARS1 PSME2 XPO1 GFPT1 AAR2 MSN GMPS FASN KDR	2.97e-04	657	163	15	int:AAR2
Interaction	USP24 interactions	USP24 NCS1 AAR2 XYLT1 NPTN CCAR2	3.01e-04	112	163	6	int:USP24
Interaction	BRCA2 interactions	CABLES2 BNC2 PMS2 ALKBH2 UPF1 XPO1 HUWE1 PTPA CELF3 PKLR DNAH9	3.01e-04	384	163	11	int:BRCA2
Interaction	LGALS9 interactions	MYH10 HYOU1 NUP107 EIF4A3 DARS1 UPF1 XPO1 RBM28 NPTN FASN PDCD11 ATG9A GNAS ATP2B1	3.12e-04	588	163	14	int:LGALS9
Interaction	FBXW7 interactions	MYH10 COL12A1 NUP107 EIF4A3 UBR4 GATB PHF6 ELP1 DARS1 CHD1 UPF1 XPO1 HUWE1 RBM28 GFPT1 MSN KMT2D SARS1 GLYR1 SMARCA1 MACF1 PML	3.25e-04	1215	163	22	int:FBXW7
Interaction	TXNIP interactions	UBR4 XPO1 HUWE1 HSPA13 EIF4B SMARCA1 KDR HSPB2	3.39e-04	212	163	8	int:TXNIP
Interaction	GRWD1 interactions	UBR4 ELP1 UPF1 XPO1 HUWE1 RBM28 FASN KMT2D RHOBTB2 METTL18 PDCD11	3.44e-04	390	163	11	int:GRWD1
GeneFamily	Collagens	COL6A1 COL6A3 COL12A1 COL6A6	2.20e-04	46	117	4	490
GeneFamily	EF-hand domain containing	GPD2 TBC1D9B SPTA1 CAPN3 ZZEF1 NCS1 MACF1	5.59e-04	219	117	7	863
GeneFamily	Elongator acetyltransferase complex	ELP1 ELP2	6.12e-04	6	117	2	539
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ARHGEF12 MCF2L VAV1	8.81e-04	66	117	4	722
GeneFamily	Phosphatidylinositol 3-kinase subunits	PIK3C2B PIK3C2G	1.13e-03	8	117	2	831
GeneFamily	CD molecules\|Toll like receptors	TLR2 TLR3	1.81e-03	10	117	2	948
GeneFamily	UPF1 like RNA helicases	UPF1 IGHMBP2	2.20e-03	11	117	2	1169
GeneFamily	RNA binding motif containing	RBFOX3 RBM28 CELF3 EIF4B SPEN RBM17	2.64e-03	213	117	6	725
GeneFamily	Proteasome	PSMC4 PSMD12 PSME2	2.70e-03	43	117	3	690
Coexpression	MENON_FETAL_KIDNEY_3_STROMAL_CELLS	COL6A3 MYH10 TNC CCDC88A MACF1 GNAS ATP2B1	7.78e-07	81	164	7	M39253
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	NIBAN1 WWC3 RPS6KA5 DUSP2 PARP8 UBR4 USP24 ELP1 DARS1 CHD1 PSME2 XPO1 HUWE1 MSN PAPOLG PPP4R3B KMT2D CCDC88A TBC1D4 GIMAP8 EIF4B MACF1 GNAS SPEN VAV1 MAP3K2	2.05e-06	1492	164	26	M40023
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	CYTH3 DUSP2 CHD1 RYK HSPA13 KMT2D SPEN ATP2B1 MAP3K2	3.59e-06	192	164	9	M8272
Coexpression	GSE29618_BCELL_VS_PDC_UP	WWC3 TRIO SIPA1L3 RYK MSN PIK3C2B MACF1 ATP2B1 ALOX5	4.24e-06	196	164	9	M4940
Coexpression	GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	B4GALNT1 ZNF180 WRN PHF6 MUS81 ZZEF1 CSAD AP1G2 PML	5.00e-06	200	164	9	M6208
Coexpression	GSE3982_BASOPHIL_VS_TH2_UP	GARNL3 AKAP17A PARP8 ZZEF1 PAPOLG FCGBP CSAD MACF1 TRIM37	5.00e-06	200	164	9	M5566
Coexpression	NABA_CORE_MATRISOME	COL6A1 COL6A3 GLDN COL12A1 COL6A6 TNC ECM2 MATN2 LAMA2 PODN	8.31e-06	270	164	10	MM17057
Coexpression	NABA_CORE_MATRISOME	COL6A1 COL6A3 GLDN COL12A1 COL6A6 TNC ECM2 MATN2 LAMA2 PODN	9.75e-06	275	164	10	M5884
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	DOCK4 RBFOX3 ANK3 COL6A6 STK32B ARHGEF12 FAXC MAGI3 LARP1B NCS1 PIEZO2 CCDC88A NALCN CSAD CELF3 MCF2L HS6ST3 ATP2B1 WNK3 MAP3K2	2.06e-05	1106	164	20	M39071
Coexpression	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	LARP1B GFPT1 NCS1 KMT2D PTPRZ1 EIF4B PODN HS6ST3	2.84e-05	191	164	8	M8671
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_UP	EIF4A3 USP24 TOMM20 DARS1 HUWE1 HSPA13 CCDC88A PIK3C2G EIF4B CENPI SMARCA1 PDCD11 AP1G2 ATP2B1	3.29e-05	612	164	14	M4772
Coexpression	GSE42021_TREG_VS_TCONV_PLN_UP	DOCK4 RPS6KA5 TNFSF10 PSME2 APOL1 JAK2 TLR3 PML	3.95e-05	200	164	8	M9572
Coexpression	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	HTR2C ECM2 GATB FCGBP DNAH17 TLR3 TET3 PLCE1	3.95e-05	200	164	8	M5192
Coexpression	CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE	COL6A1 COL6A3 NIBAN1 COL12A1 COL6A6	5.50e-05	65	164	5	M39309
Coexpression	BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS	NIBAN1 DUSP2 CCDC88A FCGBP TBC1D4 ATP2B1 ALOX5 MAP3K2	6.36e-05	214	164	8	M40005
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	NIBAN1 TNFSF10 TNC DUSP2 PARP8 IQSEC2 CHD1 JAK2 TLR3 MCF2L PML	6.90e-05	418	164	11	M12676
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	B3GALNT1 MYH10 MATN2 RRM2B WRN CHD1 PSMD12 XPO1 PIEZO2 CCDC88A PARPBP HSPB2 MAP3K2 RBM17	6.93e-05	656	164	14	M18979
Coexpression	TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL	DOCK4 COL6A3 MYH10 COL6A6 PIEZO2 ABCA6 MACF1	8.07e-05	164	164	7	M41676
Coexpression	GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN	NIBAN1 USP24 TOMM20 RYK SARS1 GNAS L3MBTL3	8.38e-05	165	164	7	M6685
Coexpression	SESTO_RESPONSE_TO_UV_C8	MYH10 TNFSF10 TOMM20 FASN PTPRZ1	8.42e-05	71	164	5	M2948
Coexpression	GU_PDEF_TARGETS_UP	DOCK4 COL6A1 COL6A3 TNC PLCE1	8.42e-05	71	164	5	M3955
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	NIBAN1 TNFSF10 TNC DUSP2 PARP8 IQSEC2 CHD1 JAK2 TLR3 MCF2L PML	9.82e-05	435	164	11	MM1221
Coexpression	NABA_BASEMENT_MEMBRANES	COL6A1 COL6A3 COL6A6 LAMA2	1.13e-04	40	164	4	M5887
Coexpression	GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP	DOCK4 HYOU1 TRIO CHD1 MFN2 ATG4C SPEN	1.17e-04	174	164	7	M397
Coexpression	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	MYH10 COL12A1 LAMA2 CCDC88A TLR2 PLAU ALOX5	1.34e-04	178	164	7	M17079
Coexpression	ONKEN_UVEAL_MELANOMA_UP	DOCK4 COL6A1 WWC3 TRIO BDH2 PSME2 RBM28 MSN FASN PTPA AP1G2 MACF1 KDR GNAS ATP2B1	1.39e-04	790	164	15	M12490
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	DOCK4 CABLES2 BNC2 KLHL1 RBFOX3 ANK3 STK32B CCDC88A NALCN CSAD CELF3 MCF2L HS6ST3 ATP2B1	1.43e-04	703	164	14	M39070
Coexpression	NABA_COLLAGENS	COL6A1 COL6A3 COL12A1 COL6A6	1.51e-04	43	164	4	MM17060
Coexpression	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	MYH10 ANK3 TNFSF10 HSPA13 CCDC88A	1.57e-04	81	164	5	M17082
Coexpression	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	NUP107 WRN XPO1 MACF1 KDR	1.57e-04	81	164	5	M8180
Coexpression	NABA_COLLAGENS	COL6A1 COL6A3 COL12A1 COL6A6	1.65e-04	44	164	4	M3005
Coexpression	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN	TRIO MATN2 PARP8 MAGI3 CCDC88A TBC1D4	2.48e-04	139	164	6	M2928
Coexpression	ZHU_SKIL_TARGETS_UP	HYOU1 ECM2 PLAU	2.54e-04	20	164	3	M2273
Coexpression	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	ANK3 RPS6KA5 CYTH3 ARHGEF12 GLYR1 SPEN ALOX5	2.58e-04	198	164	7	M3325
Coexpression	GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN	PMS2 B4GALNT1 RRM2B USP24 RBM28 MSN MTERF2	2.67e-04	199	164	7	M7183
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	UBR4 GATB XPO1 AAR2 YIPF2 CCAR2 TRIM37	2.67e-04	199	164	7	M4977
Coexpression	GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	TNFSF10 PSME2 KMT2D GIMAP8 STRADA SPEN ATP2B1	2.67e-04	199	164	7	M6605
Coexpression	DESCARTES_FETAL_EYE_STROMAL_CELLS	COL6A1 COL6A3 COL12A1 COL6A6 PODN	2.72e-04	91	164	5	M40180
Coexpression	GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN	GPD2 CABLES2 COL12A1 PARP8 MAGI3 TOMM20 TLR3	2.75e-04	200	164	7	M5811
Coexpression	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	DOCK4 RPS6KA5 TNFSF10 PSME2 APOL1 TLR3 PML	2.75e-04	200	164	7	M9586
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN	DUSP2 PARP8 USP24 PSME2 KDR ZC3H12C RBM17	2.75e-04	200	164	7	M3981
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN	NUP107 RYK JAK2 PPP4R3B SARS1 TLR2 ZC3H12C	2.75e-04	200	164	7	M3891
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 BNC2 COL6A3 COL12A1 COL6A6 TNC ECM2 LAMA2 KLHL29 ABCA6 PODN KDR	1.24e-11	200	164	12	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NIBAN1 MYH10 RBFOX3 GARNL3 TNC ECM2 LAMA2 NALCN PODN HS6ST3	1.33e-10	190	164	11	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NIBAN1 MYH10 RBFOX3 GARNL3 TNC ECM2 LAMA2 NALCN PODN HS6ST3	1.33e-10	190	164	11	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL12A1 COL6A6 ECM2 MATN2 LAMA2 GLP2R KLHL29 PIEZO2 ABCA6	1.49e-10	192	164	11	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 COL12A1 COL6A6 MATN2 LAMA2 GLP2R PIEZO2 ABCA6 PODN	1.49e-10	192	164	11	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	DOCK4 BNC2 COL6A3 MYH10 GLDN ANK3 COL6A6 TNC LAMA2 PIEZO2 MACF1	1.96e-10	197	164	11	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A1 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6 PTPRZ1 MACF1 HSPB2	2.19e-10	199	164	11	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A1 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6 PTPRZ1 MACF1 HSPB2	2.19e-10	199	164	11	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A1 COL6A3 COL12A1 TNC MATN2 LAMA2 GLP2R PIEZO2 ABCA6 PODN	1.57e-09	182	164	10	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 COL6A6 MATN2 LAMA2 GLP2R PIEZO2 ABCA6 PODN	2.63e-09	192	164	10	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 COL6A6 MATN2 LAMA2 GLP2R PIEZO2 ABCA6 PODN	2.76e-09	193	164	10	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 BNC2 COL6A3 COL12A1 ECM2 LAMA2 GLP2R PIEZO2 ABCA6 PODN	3.05e-09	195	164	10	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 PODN MACF1	3.21e-09	196	164	10	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN MACF1	3.21e-09	196	164	10	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A1 BNC2 COL6A3 MYH10 GLDN COL6A6 LAMA2 PIEZO2 ABCA6 PODN	3.53e-09	198	164	10	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN MACF1	3.53e-09	198	164	10	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	ASK452-Mesenchymal-Fibroblast\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A1 COL6A3 MYH10 COL6A6 ECM2 MATN2 LAMA2 ABCA6 PODN PLAU	3.71e-09	199	164	10	4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6
ToppCell	ASK452-Mesenchymal\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A1 COL6A3 MYH10 COL6A6 ECM2 MATN2 LAMA2 ABCA6 PODN PLAU	3.71e-09	199	164	10	93e85e3731a9ece9aee3eb82c5dfdad331ee62d6
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A1 COL6A3 MYH10 COL6A6 TNC PIEZO2 ABCA6 PTPRZ1 MACF1 HSPB2	3.71e-09	199	164	10	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 PIEZO2 ABCA6 PTPRZ1 MACF1	3.89e-09	200	164	10	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 PIEZO2 ABCA6 PTPRZ1 MACF1	3.89e-09	200	164	10	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 PIEZO2 ABCA6 PODN	3.89e-09	200	164	10	6e3d1ae0ef84d3075afa40129a41169996462672
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 PIEZO2 ABCA6 PTPRZ1 MACF1	3.89e-09	200	164	10	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 PIEZO2 ABCA6 PODN	3.89e-09	200	164	10	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	cellseq-Mesenchymal-Fibroblastic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 PODN MACF1	3.89e-09	200	164	10	8978867bf69c830b1e48cac2ad6b512dbe60f149
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 ABCA6 PODN HSPB2	2.27e-08	179	164	9	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A1 NIBAN1 GLDN COL12A1 ECM2 LAMA2 NALCN HS6ST3 PLCE1	2.75e-08	183	164	9	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 ECM2 MATN2 LAMA2 GLP2R ABCA6 PODN	3.02e-08	185	164	9	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 COL6A3 MYH10 ANK3 TNC MATN2 LAMA2 NALCN PODN	3.02e-08	185	164	9	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 PODN	3.17e-08	186	164	9	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL6A3 NIBAN1 COL12A1 ANK3 TNC CYTH3 LAMA2 PIEZO2 PLCE1	3.17e-08	186	164	9	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL6A1 BNC2 COL6A3 MYH10 ECM2 LAMA2 NALCN ABCA6 PODN	3.32e-08	187	164	9	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DOCK4 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 MACF1	3.32e-08	187	164	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A6 ECM2 MATN2 STK32B BDH2 LAMA2 NCS1 PODN	3.47e-08	188	164	9	bba6b273bd47dd0e27fde914e9e6fc9d76fd5176
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A1 COL6A3 COL12A1 COL6A6 ECM2 MATN2 LAMA2 CNTN2 PLCE1	3.64e-08	189	164	9	40764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A1 COL6A3 COL12A1 COL6A6 ECM2 MATN2 LAMA2 CNTN2 PLCE1	3.64e-08	189	164	9	eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN	3.81e-08	190	164	9	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 NIBAN1 MYH10 TNC CYTH3 ARHGEF12 MSN MACF1 ATP2B1	3.81e-08	190	164	9	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A1 COL6A3 COL12A1 COL6A6 ECM2 MATN2 LAMA2 CNTN2 PLCE1	3.98e-08	191	164	9	5271198116343c07202649889057e5774d7fdde3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 TNC CYTH3 MATN2 LAMA2 XYLT1 PIEZO2 NALCN	3.98e-08	191	164	9	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 MACF1	3.98e-08	191	164	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 ABCA6 PODN	3.98e-08	191	164	9	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 ABCA6 PODN	3.98e-08	191	164	9	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 TNC CYTH3 MATN2 LAMA2 XYLT1 PIEZO2 NALCN	3.98e-08	191	164	9	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 BNC2 COL6A3 MYH10 COL6A6 TNC XYLT1 PIEZO2 ABCA6	4.16e-08	192	164	9	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 MACF1	4.16e-08	192	164	9	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A1 BNC2 COL6A3 COL12A1 TNC CYTH3 LAMA2 KLHL29 ABCA6	4.16e-08	192	164	9	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 ECM2 MATN2 LAMA2 PIEZO2 ABCA6 PODN	4.16e-08	192	164	9	c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 COL6A1 BNC2 COL6A3 MYH10 LAMA2 PIEZO2 ABCA6 MACF1	4.35e-08	193	164	9	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 COL6A1 BNC2 COL6A3 MYH10 LAMA2 PIEZO2 ABCA6 MACF1	4.35e-08	193	164	9	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6	4.35e-08	193	164	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL12A1 COL6A6 ECM2 GLP2R KLHL29 PIEZO2 ABCA6	4.55e-08	194	164	9	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A1 BNC2 COL6A3 COL12A1 TNC LAMA2 KLHL29 XYLT1 ABCA6	4.55e-08	194	164	9	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 NALCN ABCA6	4.55e-08	194	164	9	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6	4.76e-08	195	164	9	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 TNC MATN2 LAMA2 XYLT1 PIEZO2 ABCA6 HS6ST3	4.76e-08	195	164	9	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 ECM2 MATN2 LAMA2 PIEZO2 ABCA6 PODN	4.76e-08	195	164	9	1236dc60288c7dd91868e86e9174a2dacd3b11b3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NIBAN1 RBFOX3 ECM2 MATN2 LAMA2 JAK2 NALCN HS6ST3	4.97e-08	196	164	9	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A1 NIBAN1 TRIO CYTH3 ECM2 MATN2 LAMA2 PIEZO2 PTPRZ1	4.97e-08	196	164	9	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 PIEZO2 ABCA6	4.97e-08	196	164	9	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK4 COL6A1 BNC2 COL6A3 COL6A6 LAMA2 PIEZO2 ABCA6 MACF1	4.97e-08	196	164	9	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN	4.97e-08	196	164	9	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NIBAN1 RBFOX3 ECM2 MATN2 LAMA2 JAK2 NALCN HS6ST3	4.97e-08	196	164	9	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL6A1 BNC2 COL6A3 MYH10 TNC LAMA2 PIEZO2 CENPI PARPBP	4.97e-08	196	164	9	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 MACF1	4.97e-08	196	164	9	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 MACF1	4.97e-08	196	164	9	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 COL12A1 ECM2 LAMA2 GLP2R ABCA6 PODN HSPB2	5.19e-08	197	164	9	c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 MACF1	5.19e-08	197	164	9	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN MACF1	5.19e-08	197	164	9	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 KLHL29 ABCA6 PODN	5.19e-08	197	164	9	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A1 BNC2 COL6A3 MYH10 COL12A1 TNC LAMA2 PIEZO2 ABCA6	5.19e-08	197	164	9	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 PIEZO2 ABCA6	5.19e-08	197	164	9	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 TNC ECM2 MATN2 LAMA2 NALCN ABCA6 PODN	5.19e-08	197	164	9	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	COL6A1 COL6A3 MYH10 ECM2 LAMA2 PIEZO2 ABCA6 PODN HSPB2	5.42e-08	198	164	9	2d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN	5.42e-08	198	164	9	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN	5.42e-08	198	164	9	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6	5.42e-08	198	164	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 MACF1	5.42e-08	198	164	9	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	distal-mesenchymal-Alveolar_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 MACF1	5.66e-08	199	164	9	28c1722deef3b8347371c7359be7c64b95780de3
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 PODN HSPB2	5.66e-08	199	164	9	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	distal-mesenchymal-Alveolar_Fibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 ECM2 PIEZO2 ABCA6 MACF1 HSPB2	5.66e-08	199	164	9	fb23ecce41e31e2cc01814e3c0add756f489561f
ToppCell	distal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL12A1 TNC ECM2 MATN2 LAMA2 PODN	5.66e-08	199	164	9	1f20addc0d138fec02ed6ca4c518169c568de263
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A1 COL6A3 MYH10 COL6A6 TNC XYLT1 JAK2 FASN ABCA6	5.66e-08	199	164	9	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL6A1 BNC2 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6	5.66e-08	199	164	9	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	COL6A1 COL6A3 MYH10 COL6A6 TNC ECM2 LAMA2 ABCA6 PODN	5.66e-08	199	164	9	7a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 MACF1	5.66e-08	199	164	9	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	distal-mesenchymal-Alveolar_Fibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 ECM2 PIEZO2 ABCA6 MACF1 HSPB2	5.66e-08	199	164	9	655d07cf9a2fd9b945a2ed4f824cba0297de72a8
ToppCell	normal_Lung-Fibroblasts\|normal_Lung / Location, Cell class and cell subclass	COL6A1 COL6A3 MYH10 ECM2 MATN2 LAMA2 ABCA6 PODN HSPB2	5.91e-08	200	164	9	803cf7f1382d07220249029cd220233232027689
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN	5.91e-08	200	164	9	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL6A1 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6 MACF1	5.91e-08	200	164	9	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL6A1 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN HSPB2	5.91e-08	200	164	9	137f8f9d255c66336d4f8b44b2e3f3de721f2bf0
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	COL6A1 BNC2 COL6A3 COL12A1 ECM2 LAMA2 ABCA6 PODN HSPB2	5.91e-08	200	164	9	bfa73bc5f8a6c7de8353ca049a921ef19f7f4437
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A1 COL6A3 MYH10 COL6A6 TNC LAMA2 PIEZO2 ABCA6 MACF1	5.91e-08	200	164	9	a510deaada669e690329183e18df02870bd204b3
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 BNC2 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN	5.91e-08	200	164	9	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL6A1 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN HSPB2	5.91e-08	200	164	9	25d3865aa2ced11a5ed40013e83b47d942fdf582
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 COL6A3 MYH10 TNC ECM2 LAMA2 PIEZO2 ABCA6 PODN	5.91e-08	200	164	9	54806080b5e97859ee6a4a9b4f19e22021c218f5
ToppCell	Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	COL6A1 BNC2 COL6A3 COL6A6 ECM2 LAMA2 ABCA6 PODN HSPB2	5.91e-08	200	164	9	cdaf462b1db29dab61038eeab5ddd3eef3386763
ToppCell	distal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A3 MYH10 COL6A6 ECM2 PIEZO2 ABCA6 MACF1 HSPB2	5.91e-08	200	164	9	20112be28f80baffad92641c9cfd7c3718967dbb
ToppCell	Biopsy_Other_PF-Mesenchymal-Myofibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	COL6A1 COL6A3 MYH10 COL6A6 ECM2 LAMA2 PIEZO2 ABCA6 PODN	5.91e-08	200	164	9	e504570fd7eec1524c401b1cfa9d10822d80d994
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A1 COL6A3 MYH10 COL6A6 LAMA2 PIEZO2 ABCA6 PODN HSPB2	5.91e-08	200	164	9	c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10
Computational	Genes in the cancer module 156.	COL6A1 WWC3 NUP107 NCS1	5.29e-05	22	104	4	MODULE_156
Computational	Genes upregulated in subsets of cells of a given type within various tumors	COL12A1 TRIO ARHGEF12 MACF1 SPEN	1.15e-04	50	104	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; HL60; HT_HG-U133A	TNFSF10 CAPN3 PTPA TGFBRAP1 IGHMBP2 RHOBTB2 PDCD11 AP1G2 PLAU GNA12	1.18e-06	190	163	10	1334_DN
Drug	wartmannin	MYH10 HTR2C RPS6KA5 TNFSF10 CYTH3 DUSP2 UPF1 JAK2 FASN PTPA TBC1D4 MAPK15 PIK3C2B PIK3C2G TLR2 KDR PLAU VAV1 HSPB2	5.91e-06	811	163	19	CID000005691
Drug	LY294002	MYH10 RPS6KA5 TNFSF10 CYTH3 DUSP2 GLP2R JAK2 FASN PTPA MAPK15 PIK3C2B PIK3C2G TLR2 TLR3 KDR PLAU VAV1 HSPB2	7.35e-06	748	163	18	CID000003973
Drug	AC1L1KMJ	COL6A1 COL6A3 COL12A1 ANK3 SPTA1 DUSP2 LAMA2 MSN MAPK15 PIK3C2G TLR2 MACF1 VAV1 MAP3K2	8.91e-06	476	163	14	CID000030956
Drug	12(S)-hydroxyeicosatetraenoic acid	COL6A1 COL6A3 COL12A1 DUSP2 MAPK15 PIK3C2B PIK3C2G ALOX5 PLCE1	9.22e-06	189	163	9	CID000001413
Drug	foscarnet	COL6A1 COL6A3 COL12A1 RRM2B DUSP2 GLP2R TLR2 TLR3 TRIM37	9.62e-06	190	163	9	CID000003414
Drug	Estrone [53-16-7]; Up 200; 14.8uM; HL60; HT_HG-U133A	DOCK4 MYH10 HYOU1 IQSEC2 HSPA13 IGHMBP2 DNAH17 ALOX5 PML	1.14e-05	194	163	9	3071_UP
Drug	vanadyl	RPS6KA5 DUSP2 WRN PTPA MAPK15 PIK3C2G PTPRZ1 DNAH17 ATP2B1 DNAH9 VAV1	1.40e-05	307	163	11	CID000061671
Disease	Ullrich congenital muscular dystrophy	COL6A1 COL6A3 COL12A1	6.12e-07	4	159	3	cv:C4551860
Disease	Bethlem myopathy	COL6A1 COL6A3 COL12A1	6.12e-07	4	159	3	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A1 COL6A3 COL12A1	6.12e-07	4	159	3	C1834674
Disease	Ullrich congenital muscular dystrophy 1	COL6A1 COL6A3 COL12A1	6.12e-07	4	159	3	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A1 COL6A3 COL12A1	6.12e-07	4	159	3	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A1 COL6A3 COL12A1	6.12e-07	4	159	3	DOID:0050558 (is_implicated_in)
Disease	gastric adenocarcinoma (is_implicated_in)	XPO1 KMT2D PLCE1	2.45e-05	11	159	3	DOID:3717 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy (implicated_via_orthology)	COL6A1 COL6A3	2.89e-05	2	159	2	DOID:0050558 (implicated_via_orthology)
Disease	fish oil supplement exposure measurement, total cholesterol measurement	USP24 ABCA6	2.89e-05	2	159	2	EFO_0004574, EFO_0600007
Disease	intellectual disability (implicated_via_orthology)	RBFOX3 UBR4 CAPN3 RYK ELP2	5.43e-05	75	159	5	DOID:1059 (implicated_via_orthology)
Disease	Cafe-au-Lait Spots	PMS2 GNAS	8.63e-05	3	159	2	C0221263
Disease	limited scleroderma (is_marker_for)	JAK2 KDR	8.63e-05	3	159	2	DOID:1577 (is_marker_for)
Disease	muscular dystrophy (is_implicated_in)	COL6A3 CAPN3 LAMA2	9.88e-05	17	159	3	DOID:9884 (is_implicated_in)
Disease	Medulloblastoma	PMS2 STRADA L3MBTL3 VAV1	1.54e-04	50	159	4	C0025149
Disease	Intellectual Disability	TRIO EIF4A3 RRM2B RBM28 FASN RHOBTB2 MACF1 ELP2 GNAS TET3	1.65e-04	447	159	10	C3714756
Disease	fish oil supplement exposure measurement, low density lipoprotein cholesterol measurement	USP24 ABCA6	1.72e-04	4	159	2	EFO_0004611, EFO_0600007
Disease	eye disease (is_marker_for)	TLR2 TLR3	1.72e-04	4	159	2	DOID:5614 (is_marker_for)
Disease	Neoplasm Metastasis	CTU2 PMS2 TNFSF10 PIK3C2B PLAU ALOX5 PML	1.83e-04	217	159	7	C0027627
Disease	Deep Vein Thrombosis	JAK2 KDR PLAU	1.90e-04	21	159	3	C0149871
Disease	Venous Thrombosis	JAK2 KDR PLAU	1.90e-04	21	159	3	C0042487
Disease	carotid stenosis (implicated_via_orthology)	TLR2 MFN2	2.85e-04	5	159	2	DOID:13001 (implicated_via_orthology)
Disease	Early Pregnancy Loss	COL6A1 COL6A3 TNFSF10 ECM2 JAK2	3.17e-04	109	159	5	C3830362
Disease	Spontaneous abortion	COL6A1 COL6A3 TNFSF10 ECM2 JAK2	3.17e-04	109	159	5	C0000786
Disease	Miscarriage	COL6A1 COL6A3 TNFSF10 ECM2 JAK2	3.17e-04	109	159	5	C4552766
Disease	Abortion, Tubal	COL6A1 COL6A3 TNFSF10 ECM2 JAK2	3.17e-04	109	159	5	C0000822
Disease	Pathologic Neovascularization	TNFSF10 KDR	4.27e-04	6	159	2	C0027686
Disease	congenital muscular dystrophy (implicated_via_orthology)	COL6A1 COL6A3	4.27e-04	6	159	2	DOID:0050557 (implicated_via_orthology)
Disease	ARTHROGRYPOSIS, DISTAL, TYPE 2B	PIEZO2 NALCN	4.27e-04	6	159	2	C1834523
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	NUP107 APOL1 PLCE1	5.60e-04	30	159	3	C1868672
Disease	asthma (is_marker_for)	TNC TLR3 KDR PLAU ALOX5	6.17e-04	126	159	5	DOID:2841 (is_marker_for)
Disease	esophagus squamous cell carcinoma (is_marker_for)	XPO1 JAK2 KMT2D TET3	6.97e-04	74	159	4	DOID:3748 (is_marker_for)
Disease	urinary bladder cancer (is_implicated_in)	PMS2 TLR2 KDR PLAU	7.70e-04	76	159	4	DOID:11054 (is_implicated_in)
Disease	Muscular Dystrophy	COL6A1 LAMA2	7.91e-04	8	159	2	C0026850
Disease	ovarian neoplasm	BNC2 PMS2 TNFSF10 FASN ALOX5	8.14e-04	134	159	5	C0919267
Disease	Malignant neoplasm of ovary	BNC2 PMS2 TNFSF10 FASN ALOX5	9.00e-04	137	159	5	C1140680
Disease	lung non-small cell carcinoma (is_implicated_in)	XPO1 JAK2 KMT2D KDR PLAU	9.60e-04	139	159	5	DOID:3908 (is_implicated_in)
Disease	Cleft Palate	BNC2 EIF4A3 CHD1 RYK	9.78e-04	81	159	4	C0008925
Disease	Distal arthrogryposis	PIEZO2 NALCN	1.01e-03	9	159	2	cv:C0265213
Disease	Erythrocytosis familial, 1	JAK2 PKLR	1.01e-03	9	159	2	C4551637
Disease	Schizophrenia	DOCK4 HTR2C ANK3 LAMA2 NCS1 NPTN PTPRZ1 TLR2 TLR3 KDR GNAS WNK3 PML	1.03e-03	883	159	13	C0036341
Disease	Reperfusion Injury	TLR2 KDR PLAU ALOX5	1.39e-03	89	159	4	C0035126
Disease	colitis (biomarker_via_orthology)	LCT TLR3 KDR	1.51e-03	42	159	3	DOID:0060180 (biomarker_via_orthology)
Disease	high grade glioma (is_marker_for)	KDR PLAU CNTN2	1.51e-03	42	159	3	DOID:3070 (is_marker_for)
Disease	diffuse scleroderma (is_implicated_in)	WRN TLR2	1.54e-03	11	159	2	DOID:1580 (is_implicated_in)
Disease	response to ondansetron, QT interval	COL6A1 TLR3	1.54e-03	11	159	2	EFO_0004682, EFO_0020997
Disease	Childhood Medulloblastoma	STRADA L3MBTL3 VAV1	1.62e-03	43	159	3	C0278510
Disease	nasopharynx carcinoma (is_marker_for)	JAK2 KDR SPEN	1.62e-03	43	159	3	DOID:9261 (is_marker_for)
Disease	Melanotic medulloblastoma	STRADA L3MBTL3 VAV1	1.62e-03	43	159	3	C1275668
Disease	Medullomyoblastoma	STRADA L3MBTL3 VAV1	1.62e-03	43	159	3	C0205833
Disease	Desmoplastic Medulloblastoma	STRADA L3MBTL3 VAV1	1.62e-03	43	159	3	C0751291
Disease	Adult Medulloblastoma	STRADA L3MBTL3 VAV1	1.62e-03	43	159	3	C0278876
Disease	asthma (is_implicated_in)	TNC ELP1 TLR2 TLR3 ALOX5	1.65e-03	157	159	5	DOID:2841 (is_implicated_in)
Disease	immunoglobulin isotype switching measurement	PARP8 UBR4 PAPOLG	1.73e-03	44	159	3	EFO_0010128
Disease	Squamous cell carcinoma of esophagus	PSME2 FASN KMT2D PLCE1	1.77e-03	95	159	4	C0279626
Disease	chronic kidney disease	COL6A3 ECM2 SIPA1L3 APOL1 L3MBTL3 TET3	1.78e-03	235	159	6	EFO_0003884
Disease	Congenital muscular dystrophy	COL6A1 LAMA2	1.84e-03	12	159	2	cv:C0699743
Disease	Thromboembolism	JAK2 PLAU	1.84e-03	12	159	2	C0040038
Disease	Prostatic Neoplasms	TNFSF10 CHD1 XPO1 JAK2 KMT2D SMARCA1 PLAU SPEN ALOX5 PML	1.94e-03	616	159	10	C0033578
Disease	Malignant neoplasm of prostate	TNFSF10 CHD1 XPO1 JAK2 KMT2D SMARCA1 PLAU SPEN ALOX5 PML	1.94e-03	616	159	10	C0376358
Disease	Alzheimer disease, APOE carrier status	COL6A3 PMS2 GFPT1 L3MBTL3	1.98e-03	98	159	4	EFO_0007659, MONDO_0004975
Disease	Malignant neoplasm of breast	CTU2 TBC1D9B TNFSF10 UBR4 LAMA2 ELP1 APOL1 FASN KMT2D MACF1 KDR SPEN L3MBTL3 DNAH9	2.08e-03	1074	159	14	C0006142
Disease	Coffin-Siris syndrome	PHF6 SMARCA1	2.16e-03	13	159	2	C0265338
Disease	colon carcinoma (is_marker_for)	KMT2D TLR3	2.16e-03	13	159	2	DOID:1520 (is_marker_for)
Disease	pancreatic cancer (is_marker_for)	EIF4A3 XPO1 GNAS ALOX5	2.21e-03	101	159	4	DOID:1793 (is_marker_for)
Disease	Kuhnt-Junius degeneration (is_marker_for)	TLR2 TLR3	2.52e-03	14	159	2	DOID:10873 (is_marker_for)
Disease	Myocardial Ischemia	MSN JAK2 NPTN KDR GNA12	2.71e-03	176	159	5	C0151744
Disease	serum alanine aminotransferase measurement	COL12A1 HYOU1 TNFSF10 KMT5A XPO1 XYLT1 NPTN STRADA RHOBTB2 L3MBTL3 ALOX5 PLCE1	2.72e-03	869	159	12	EFO_0004735
Disease	hepatocellular carcinoma (biomarker_via_orthology)	CAPN3 GMPS JAK2 VAV1	2.82e-03	108	159	4	DOID:684 (biomarker_via_orthology)
Disease	Cholestasis	NIBAN1 BCS1L TLR2 GNAS	3.01e-03	110	159	4	C0008370
Disease	total blood protein measurement	CABLES2 HYOU1 ARHGEF12 XPO1 KMT2D ABCA6 MACF1 PLCE1	3.11e-03	449	159	8	EFO_0004536
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TNFSF10 CAPN3 USP24 ABCA6 MACF1 L3MBTL3	3.17e-03	264	159	6	EFO_0008317, EFO_0020944
Disease	Diffuse Large B-Cell Lymphoma	JAK2 KMT2D SPEN	3.28e-03	55	159	3	C0079744
Disease	vision disorder	MYH10 RBFOX3	3.29e-03	16	159	2	MONDO_0021084
Disease	endometriosis (biomarker_via_orthology)	KDR VAV1	3.29e-03	16	159	2	DOID:289 (biomarker_via_orthology)
Disease	breast cancer (is_marker_for)	PMS2 KMT2D MAPK15 KDR PLAU	3.35e-03	185	159	5	DOID:1612 (is_marker_for)
Disease	Carcinoma, Granular Cell	KDR PLAU ALOX5 PLCE1	3.64e-03	116	159	4	C0205644
Disease	Adenocarcinoma, Tubular	KDR PLAU ALOX5 PLCE1	3.64e-03	116	159	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	KDR PLAU ALOX5 PLCE1	3.64e-03	116	159	4	C0205642
Disease	Carcinoma, Cribriform	KDR PLAU ALOX5 PLCE1	3.64e-03	116	159	4	C0205643
Disease	Adenocarcinoma, Basal Cell	KDR PLAU ALOX5 PLCE1	3.64e-03	116	159	4	C0205641
Disease	Adenocarcinoma	KDR PLAU ALOX5 PLCE1	3.64e-03	116	159	4	C0001418
Disease	Charcot-Marie-Tooth disease type 2	IGHMBP2 MFN2	3.72e-03	17	159	2	cv:C0270914
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR2 TLR3	3.72e-03	17	159	2	DOID:8677 (biomarker_via_orthology)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO ATP2B1	3.72e-03	17	159	2	DOID:0060307 (is_implicated_in)
Disease	sinusitis (is_marker_for)	TLR2 PLAU	4.17e-03	18	159	2	DOID:0050127 (is_marker_for)
Disease	peritonsillar abscess	KLHL1 GNA12	4.17e-03	18	159	2	EFO_0007429
Disease	lean body mass	LAMA2 KLHL29 GNA12 HS6ST3 L3MBTL3 PML PLCE1	4.60e-03	379	159	7	EFO_0004995
Disease	portal hypertension (implicated_via_orthology)	JAK2 ALOX5	4.65e-03	19	159	2	DOID:10762 (implicated_via_orthology)
Disease	blood metabolite measurement	GMPS PTPA	4.65e-03	19	159	2	EFO_0005664
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAH17 DNAH9	4.65e-03	19	159	2	DOID:10003 (implicated_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	TNC GNAS	4.65e-03	19	159	2	DOID:0080322 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	PMS2 TNFSF10 PARP8 WRN CHD1 ABCA6 TLR2 KDR TNS4 GNAS	4.89e-03	702	159	10	C0009402
Disease	exercise test	WRN ZC3H12C	5.14e-03	20	159	2	EFO_0004328
Disease	corneal hysteresis	COL6A1 ABCA6	5.14e-03	20	159	2	EFO_0010066
Disease	Malignant Neoplasms	WRN FASN KDR GNAS	5.16e-03	128	159	4	C0006826
Disease	Obesity	HTR2C PHF6 GFPT1 FASN GNAS	5.17e-03	205	159	5	C0028754
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	FASN PKLR MFN2	5.25e-03	65	159	3	DOID:0080208 (biomarker_via_orthology)
Disease	Adenocarcinoma of lung (disorder)	TNFSF10 FASN KDR ALOX5 VAV1	5.28e-03	206	159	5	C0152013

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLFGKAEADEIFQEL	ALKBH2	71	Q6NS38
VVDEEVFFQLSVVKG	CCAR2	71	Q8N163
IFEQFGRIFELTVIK	CELF3	26	Q5SZQ8
VTDGVVNFFLARTDK	B4GALNT1	431	Q00973
VNFFLARTDKVREVG	B4GALNT1	436	Q00973
EIITLQQFLRFGETK	BNC2	241	Q6ZN30
QQFLRFGETKSIVEL	BNC2	246	Q6ZN30
GTDRKVFFNILEEAR	BCS1L	141	Q9Y276
VDEGVEEFFSKRLIQ	CARMIL2	1056	Q6F5E8
TLLGFKTFLEVRDQE	ABCA6	1166	Q8N139
AKRLFFEGATVVILN	AAR2	11	Q9Y312
VIGLRDEEKVFVNNT	HTR2C	191	P28335
KVFEREGVQLNLSFI	AP1G2	671	O75843
FIFAHVRGETKEVEV	GIPC3	101	Q8TF64
LVRFEFGQETSQTLK	GLDN	391	Q6ZMI3
EVGLLEFFQNVIKET	GATB	401	O75879
ENIKGFSDAEIRRFI	CHD1	1121	O14646
ADLERREAVFGKNFI	ATP2B1	76	P20020
VIAGNVEEFRKDFIS	ATG4C	71	Q96DT6
GKSEVRDLFVAERQF	ARHGEF12	1201	Q9NZN5
VNEGKTVFIRNLSFD	RBM28	331	Q9NW13
QFGKILDVEIIFNER	RBFOX3	121	A6NFN3
ENILVQEFVKFGSLD	JAK2	621	O60674
FFRTLGLQTKEEVSI	NUP107	556	P57740
FINFIDKLDEILGEI	PARPBP	256	Q9NWS1
VLKKEIGRLEEFFQD	PIK3C2G	856	O75747
SDLKFRVNEFGALEV	L3MBTL3	31	Q96JM7
EFIIDFLEEKLGVNL	FAXC	161	Q5TGI0
IFLRFNKLAVGSVVD	PODN	551	Q7Z5L7
TVDVFQISTKERFGL	PARP8	226	Q8N3A8
DADQKGFITIVDVQR	GPD2	636	P43304
VKEFIVDILQFLDIG	MATN2	76	O00339
DVVLQRKENEGFGFV	MAGI3	851	Q5TCQ9
ELRLSEGKFQAFLDV	HSPB2	66	Q16082
VIATKQFSRGDFVVE	KMT5A	271	Q9NQR1
KDGRIEFSEFIQALS	NCS1	76	P62166
GEVVAIKKIFDAFRD	MAPK15	36	Q8TD08
FESDFIQITKRGEVI	GARIN4	46	Q8IYT1
VQGEAQKVERLIEAF	IQSEC2	846	Q5JU85
LTLEGIKQFFVAVER	EIF4A3	246	P38919
EVLTFFLLGQEAEKE	B3GALNT1	111	O75752
DEAFDFVKQRRGVIS	DUSP2	281	Q05923
FIERIQGLDFDTKAA	CCDC88A	141	Q3V6T2
KEAFTVIDQNRDGII	MYLPF	31	Q96A32
GKRFQQAVDAVEEFL	GLYR1	76	Q49A26
VDTGRELAVKQVQFD	MAP3K2	376	Q9Y2U5
QLIDQGKTVLFAFEE	PGM2	411	Q96G03
KDQVLTIGFDINEFL	LCT	306	P09848
VEHGVDIVFASFVRK	PKLR	276	P30613
DEGLKRFIIEITFKF	METTL18	356	O95568
DITQRLFFLQVKEGI	MSN	96	P26038
KVLFLFEFDEQGREL	ELP1	1241	O95163
FKVGLDLLVEFEFRT	LAMA2	2956	P24043
NDNLEIKIIDFGFAR	RPS6KA5	556	O75582
TIFAKVDRLAGIINF	PSMD12	401	O00232
ILFEVGTEENLDFKA	PTPRZ1	181	P23471
VIELFEFIRVEDIKS	PPP4R3B	636	Q5MIZ7
IKFLGDEQDQITFVT	HUWE1	416	Q7Z6Z7
RFVDFNIKGRDVIVF	HS6ST3	136	Q8IZP7
ITRQEFIDGILASKF	MACF1	7061	Q9UPN3
QAGDRIFFVSAKEVL	MFN2	296	O95140
AIKETLEFLQEQGFT	MTERF2	226	Q49AM1
QGILRTGLEEVKQFF	PIK3C2B	1016	O00750
RAVEDAFVPVIKFEF	PAPOLG	146	Q9BWT3
SVDAFQGREKDFIIL	UPF1	836	Q92900
IVTLKENERFFGDSA	HYOU1	71	Q9Y4L1
DDQVEGFAKLIRLFI	GLP2R	406	O95838
AFAIKEQGFRAIIIS	GMPS	61	P49915
KEELRDFLLQIFTVF	DOCK4	941	Q8N1I0
EKAVQEAQRAGIEIF	COL6A1	956	P12109
IGIANFVKVRAFLEV	COL12A1	451	Q99715
ENETFRKFVGNLELI	DNAH17	706	Q9UFH2
VDLKNTGREEFLTAF	FCGBP	26	Q9Y6R7
RESTAFLGFLKEQVQ	ATG9A	571	Q7Z3C6
DFIAKVIQRLEIGQD	COL6A3	466	P12111
VFQLGRFTEEDKTAV	GIMAP8	531	Q8ND71
GERDEFNIKVLQAFV	CYTH3	121	O43739
LEFRDTIFDNILKGS	GNA12	91	Q03113
RVLTSGIFETKFQVD	GNAS	201	P63092
KRDFVEERLQFFQIG	ANK3	3621	Q12955
LKEVREFLGENISNF	APOL1	251	O14791
ILRFGFLQEFSKEER	CNTN2	126	Q02246
LRAVFGVVVDEAIQK	CSAD	21	Q9Y600
LLIIFQTDFGKNEEI	ECM2	11	O94769
FEQGFREVKAILDAA	MCF2L	356	O15068
FESDFIQISKRGEVI	GARIN6	46	Q8NEG0
RFIGKIFTAEELEAE	HSPA13	101	P48723
EGFIEAQSLARKFIT	DNAH9	2011	Q9NYC9
QFVSGADEKVLRVFS	ELP2	451	Q6IA86
GKEFTNFLDTIIRAE	CENPI	411	Q92674
FVEQLRKEGVFAKEV	FASN	661	P49327
EGEFILRVFSEKRNL	CAPN3	566	P20807
TLKDVLQEGTFGRIF	RYK	331	P34925
GVTQLIDKLEERFRF	CABLES2	426	Q9BTV7
AKRLRFVAGVIFVDE	CTU2	101	Q2VPK5
ERDLKITDIIIFFQA	MYH10	781	P35580
TFIGEKEISFQIENI	COL6A6	1056	A6NMZ7
LLVLEEQEGSVNFKF	GARNL3	191	Q5VVW2
LDFLFDEEIEQIGRK	LARP1B	411	Q659C4
DVTEESIKEFFRGLN	EIF4B	106	P23588
DTRGIFRVHQFEKIE	SARS1	311	P49591
KAAQEFFQRLELGDV	RARS2	221	Q5T160
SEKFIVEGLRDLELF	STRADA	16	Q7RTN6
EDALVVSFRFGEKLF	PWWP2A	171	Q96N64
TKNIIREFASDFEVG	TRIM37	356	O94972
RFKIIGGEFTTIENQ	PLAU	176	P00749
IIFIDEIDAIATKRF	PSMC4	261	P43686
REDKFLEVEFLGQRE	SMARCA1	541	P28370
RVIQQLEGAFALVFK	GFPT1	176	Q06210
RDIQFDSEKGVDFVL	ALOX5	166	P09917
PFKEVVEAIDRSAFI	PLCE1	1461	Q9P212
VRTDGFDEFKVRLQD	PML	371	P29590
VAQFGIKDVFDNAIR	RHOBTB2	191	Q9BYZ6
FVVLLDLRTKEVVFN	SIPA1L3	896	O60292
NDFGVAIQEKVLERV	PSME2	136	Q9UL46
KAFSRQLITEGFLVE	WRN	1016	Q14191
FRETLINKGFVEIQT	DARS1	206	P14868
SVLVNFFEKRVDIGL	TBC1D9B	1211	Q66K14
EVERLDVLFNVAGFV	BDH2	71	Q9BUT1
IDGKFVFVDQRATAI	ARNTL	346	O00327
FIRFEGEVENKSLVK	AKAP17A	76	Q02040
EDVLVKVFEKFGEIR	AKAP17A	171	Q02040
RGEVVKAFVILASQF	ACSM2B	501	Q68CK6
DRLLVELGFSKVFQA	RRM2B	291	Q7LG56
VFREEDGVLIVDLQK	RNF17	611	Q9BXT8
EFQLGDAERAKAIFE	PDCD11	1771	Q14690
KDVATQILEGELFDF	RSPH3	296	Q86UC2
FLEAKELFRSGQLDV	TGFBRAP1	366	Q8WUH2
RDFLVQIKEFAGEDT	XPO1	1016	O14980
SRAEFGDFDIKTVLQ	PHF6	256	Q8IWS0
ENFRNLVFLGIDVSK	ZNF738	66	Q8NE65
FARKFEAVVNQEIIG	XYLT1	596	Q86Y38
VLGFKEIDRQTEQFE	TLR3	741	O15455
NIFQRFGEIVDIDIK	SPEN	456	Q96T58
GFSEVRVLFEKEVNE	NIBAN1	361	Q9BZQ8
RDFSDGVLVAEVIKF	SPEF1	31	Q9Y4P9
EQGITLTDVQRKVFF	TNS4	626	Q8IZW8
VLRVDDQIAIVFKVF	PTPA	206	Q15257
GFQGREKEAVILSFV	IGHMBP2	566	P38935
FLEFERVESAIKAVV	RBM17	356	Q96I25
GTFLVRQRVKDAAEF	VAV1	691	P15498
DIVNTSGRFFIINKE	NPTN	281	Q9Y639
TADEGVFDNFVLKIR	TNC	1641	P24821
DLGLKQFTVAELFTR	PIEZO2	776	Q9H5I5
EFSIKERGFEVQLRE	SCLT1	551	Q96NL6
EDFQVELVAKEGRVV	SPTA1	201	P02549
KLEELIRQFEAEFGD	TET3	706	O43151
DIIFLQGTEVIFKVA	TBC1D4	1106	O60343
ENLEIFRKNGFDFVI	PMS2	741	P54278
GVNFKIVTVDFTREE	ZNF180	71	Q9UJW8
IQVERVKFVFETENG	USP24	2466	Q9UPU5
FLEVQKRFDGDELTT	ZZEF1	2496	O43149
SVIKLNDFFVEIRGT	UGT2A3	106	Q6UWM9
ETVREEFIIFNREKL	STK32B	356	Q9NY57
FFIIEGAQEKTNLEI	KDR	751	P35968
DRFIVKLAFESDGII	ZC3H12C	336	Q9C0D7
FFDVDTSQVLDRIKG	YIPF2	86	Q9BWQ6
GIFELKENDRIFVSV	TNFSF10	246	P50591
IRDVTFLFNEEGKNI	UBR4	2046	Q5T4S7
QRKDFAGLTFLEELE	TLR2	166	O60603
VQKFFLEEIQLGEEL	TOMM20	66	Q15388
IIGEFVFDDKTRLVD	WWC3	216	Q9ULE0
ESVEAVQDLIKRFGQ	TRIO	701	O75962
EKFVEELRAIVGQAQ	WNK3	801	Q9BYP7
KAFTDLKIVVEGREF	KLHL29	326	Q96CT2
RLQFGVAVIDDKLFV	KLHL1	496	Q9NR64
FVIKVIEQGLEDLVF	KMT2D	5241	O14686
VVRELFSGFKEIFLV	NALCN	1006	Q8IZF0
TQVIDGFFVKRTADI	MUS81	391	Q96NY9